1.020EUR-2.86%Mkt Cap: 18.80M EURP/E: —Last update: 2026-06-01
Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immun…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap18.80M EUR
Enterprise Value—
Revenue (TTM)115.13M EUR
Gross Profit52.36M EUR
Net Income (TTM)-58.22M EUR
Revenue/Share—
Last Price1.020 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryFR
SectorHealthcare
IndustryMedical Devices
ISINFR0011005933
Valuation
P/E (Trailing)—
P/E (Forward)2.28
PEG—
EV/EBITDA—
EV/Revenue—
P/S0.17
P/B0.41
EPS (TTM)-4.03
EPS (Forward)0.46
52W Range
0.455051% of range1.570
52W High1.570 EUR
52W Low0.4550 EUR
Profitability
Gross Margin55.00%
Oper. Margin-20.93%
EBITDA Margin4.87%
Profit Margin-61.16%
ROE-166.59%
ROA-42.74%
Growth
Revenue Growth-8.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-5.89M EUR
CapEx (TTM)2.69M EUR
FCF Margin7.63%
FCF Yield46.72%
Net Debt53.19M EUR
Net Debt/EBITDA9.48
Balance Sheet
Debt/Equity1.76
Current Ratio3.24
Quick Ratio1.91
Book Value/Sh2.563 EUR
Cash/Share—
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 16, 2022
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.18.43M
Float—
Insiders57.60%
Institutions0.00%
Technical
SMA 500.9086 (+12.3%)
SMA 2000.8251 (+23.6%)
Beta—
S&P 52W Chg27.94%
Avg Vol (30d)104.05K
Avg Vol (10d)90.40K
Technical Indicators
RSI (14)52.1
MACD0.0491
MACD Signal0.0557
MACD Hist.-0.0067
BB Upper1.410 EUR
BB Middle1.044 EUR
BB Lower0.6779 EUR
BB Width70.15%
ATR (14)0.1409 EUR
Vol Ratio (20d)0.27x